Department of Epidemiology (Drs Costacou, Miller, Orchard), School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, United States.
Department of Epidemiology (Drs Costacou, Miller, Orchard), School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, United States.
J Clin Lipidol. 2024 Mar-Apr;18(2):e218-e229. doi: 10.1016/j.jacl.2024.01.004. Epub 2024 Jan 29.
In type 1 diabetes, women lose their relative protection (compared to men) against coronary artery disease (CAD), while high-density lipoprotein cholesterol (HDL-C) is less strongly associated with lower CAD risk in women.
We aimed to assess whether sex differences in the HDL particle concentration (HDL-P) and cholesterol efflux capacity (CEC) association with CAD may explain these findings.
HDL-P (calibrated differential ion mobility analysis) and total and ATP binding cassette transporter A1 (ABCA1)-specific CEC were quantified among 279 men and 271 women with type 1 diabetes (baseline mean age 27·8 years; diabetes duration, 19·6 years). Clinical CAD was defined as CAD death, myocardial infarction and/or coronary revascularization.
Women had higher large HDL-P levels and marginally lower concentrations of small HDL-P and ABCA1-specific CEC than men. No sex differences were observed in extra-small HDL-P, medium HDL-P and total CEC. During a median follow-up of 26 years, 37·6 % of men and 35·8 % of women developed CAD (p = 0·72). In multivariable Cox models stratified by sex (p=0·01), HDL-P was negatively associated with CAD incidence in both sexes. However, associations were stronger in men, particularly for extra-small HDL-P (hazard ratio (HR)=0·11, 95 % confidence interval (CI): 0·04-0·30; HR=0·68, 95 % CI: 0·28-1·66; p=0·001). CEC did not independently predict CAD in either sex.
Despite few absolute differences in HDL-P concentrations by sex, the HDL-P - CAD association was weaker in women, particularly for extra-small HDL-P, suggesting that HDL-P may be less efficient in providing atheroprotection in women and perhaps explaining the lack of a sex difference in CAD in type 1 diabetes.
在 1 型糖尿病患者中,女性失去了相对于男性对冠状动脉疾病(CAD)的相对保护,而高密度脂蛋白胆固醇(HDL-C)与女性 CAD 风险的降低相关性较弱。
我们旨在评估 HDL 颗粒浓度(HDL-P)和胆固醇流出能力(CEC)与 CAD 的性别差异是否可以解释这些发现。
在 279 名男性和 271 名女性 1 型糖尿病患者(基线平均年龄 27.8 岁;糖尿病病程 19.6 年)中定量测定了 HDL-P(校准差速离子迁移分析)和总胆固醇以及 ATP 结合盒转运体 A1(ABCA1)特异性 CEC。临床 CAD 定义为 CAD 死亡、心肌梗死和/或冠状动脉血运重建。
女性的大 HDL-P 水平较高,小 HDL-P 和 ABCA1 特异性 CEC 的浓度略低。小、中、大 HDL-P 和总 CEC 之间无性别差异。在中位随访 26 年期间,37.6%的男性和 35.8%的女性发生 CAD(p=0.72)。在按性别分层的多变量 Cox 模型中(p=0.01),HDL-P 与两性的 CAD 发生率均呈负相关。然而,这种关联在男性中更强,尤其是小 HDL-P(危险比(HR)=0.11,95%置信区间(CI):0.04-0.30;HR=0.68,95%CI:0.28-1.66;p=0.001)。CEC 不能独立预测两性的 CAD。
尽管两性之间的 HDL-P 浓度存在很小的绝对差异,但 HDL-P 与 CAD 的关联在女性中较弱,尤其是对于小 HDL-P,这表明 HDL-P 在女性中提供抗动脉粥样硬化保护的效率较低,可能解释了 1 型糖尿病中 CAD 无性别差异的原因。